Geographic Access & Regulatory Compliance
Educational regulatory references for investors accessing Aksoy Capital research from various jurisdictions. Not legal or tax advice — consult a licensed advisor in your jurisdiction.
1. United States (SEC)
The U.S. Securities and Exchange Commission (SEC) regulates investment advisers under the Investment Advisers Act of 1940. Aksoy Capital is not registered as an investment adviser; our content is published as research and educational material under the publisher's exemption.
- Disclosure: Every page carries a "not a registered investment adviser" disclaimer.
- Accredited investor rules: Some private offerings (e.g., hedge funds) require accredited investor status. Aksoy Capital does not market private offerings.
- Anti-fraud rules: Even publishers must avoid materially false or misleading statements. We follow internal QA gates and disclaimer discipline.
Reference: SEC Investment Adviser laws & rules.
2. European Union (MiFID II)
The Markets in Financial Instruments Directive II (MiFID II) governs investment services in the EU. EU residents accessing Aksoy Capital should note:
- Suitability rules: Personalized advice in the EU requires authorization. Aksoy Capital provides no personalized advice; research outputs are general-purpose and educational.
- UCITS-eligible products: Many U.S. ETFs (e.g., SPY) are not available to EU retail investors due to PRIIPs KID requirements. UCITS-equivalent ETFs (Ireland-domiciled, e.g., CSPX) provide similar exposure with EU-compliant disclosure.
- GDPR: Personal data is processed under our Privacy Policy.
Reference: ESMA MiFID II overview.
3. United Kingdom (FCA)
Post-Brexit, the UK's Financial Conduct Authority (FCA) maintains a similar framework to MiFID II. Key points for UK readers:
- Retail vs. professional: Most paid services targeting retail investors require FCA authorization. Aksoy Capital does not target UK retail investors with regulated services.
- Financial promotions: The FCA Section 21 regime restricts promotion of investment products to UK persons. Our research pages are educational and not promotional.
Reference: FCA.
4. Türkiye (SPK / CMB)
Sermaye Piyasası Kurulu (SPK) is Türkiye's capital markets regulator. SPK Madde 35 prohibits unlicensed investment advice.
- "Yatırım tavsiyesi değildir": Tüm Türkçe içeriklerde "yatırım tavsiyesi değildir" beyanı zorunlu. Aksoy Capital şu anda yalnızca İngilizce yayın yapmaktadır; Türkçe yayın eklendiğinde SPK uyumlu disclaimer otomatik enjekte edilecektir.
- Vergi: Türk yatırımcılar için ABD hisse senedi temettü stopajı (W-8BEN ile %30 → %15) ve estate tax ($60K eşiği) önemli konulardır. Detaylı rehber: Tax Hub (yakında).
Reference: SPK.
5. China (Cross-Border Restrictions)
The People's Republic of China imposes strict capital controls (CFIUS, SAFE) on outbound investment by mainland residents. Aksoy Capital does not target mainland Chinese users:
- Capital outflow limits: Mainland residents face annual USD purchase limits (currently $50,000) and reporting requirements.
- Brokerage access: U.S. brokerages typically restrict mainland residents from opening accounts under FATCA + CFIUS frameworks.
- Hong Kong & offshore: Hong Kong residents and PRC nationals with offshore status (e.g., overseas residents) face fewer restrictions and can typically access standard U.S. brokerages.
6. Other Restricted Jurisdictions
Sanctions-restricted jurisdictions (OFAC list: Cuba, Iran, North Korea, Russia regions, Syria, etc.) cannot access U.S. financial services. Aksoy Capital research pages may be accessible (publisher content), but paid subscriptions and any interactive financial functionality are blocked per OFAC compliance.
7. General Recommendations
- Verify your local broker's access to U.S. equities and ETFs.
- Consult a licensed tax advisor in your jurisdiction before making cross-border investment decisions.
- Review the "What This Is NOT" section of our methodology page for clarity on what Aksoy Capital does and does not provide.
8. Questions?
For jurisdiction-specific questions, email [email protected] with subject "Access & Compliance". We respond to general questions within 5 business days. We do not provide legal advice and may decline questions requiring licensed counsel.